-
1
-
-
77955039099
-
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
-
Audeh M.W., Carmichael J., Penson R.T., Friedlander M., Powell B., Bell-McGuinn K.M., Scott C., Weitzel J.N., Oaknin A., Loman N., et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. Lancet 2010, 376:245-251.
-
(2010)
Lancet
, vol.376
, pp. 245-251
-
-
Audeh, M.W.1
Carmichael, J.2
Penson, R.T.3
Friedlander, M.4
Powell, B.5
Bell-McGuinn, K.M.6
Scott, C.7
Weitzel, J.N.8
Oaknin, A.9
Loman, N.10
-
2
-
-
67649881097
-
The carboxyl terminus of Brca2 links the disassembly of Rad51 complexes to mitotic entry
-
Ayoub N., Rajendra E., Su X., Jeyasekharan A.D., Mahen R., Venkitaraman A.R. The carboxyl terminus of Brca2 links the disassembly of Rad51 complexes to mitotic entry. Curr. Biol. 2009, 19:1075-1085.
-
(2009)
Curr. Biol.
, vol.19
, pp. 1075-1085
-
-
Ayoub, N.1
Rajendra, E.2
Su, X.3
Jeyasekharan, A.D.4
Mahen, R.5
Venkitaraman, A.R.6
-
3
-
-
0033523268
-
The Breast Cancer Linkage Consortium: cancer risks in BRCA2 mutation carriers
-
Breast Cancer Linkage Consortium T
-
The Breast Cancer Linkage Consortium: cancer risks in BRCA2 mutation carriers. J. Natl. Cancer Inst. 1999, 91:1310-1316. Breast Cancer Linkage Consortium T.
-
(1999)
J. Natl. Cancer Inst.
, vol.91
, pp. 1310-1316
-
-
-
4
-
-
17244375049
-
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
-
Bryant H.E., Schultz N., Thomas H.D., Parker K.M., Flower D., Lopez E., Kyle S., Meuth M., Curtin N.J., Helleday T. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 2005, 434:913-917.
-
(2005)
Nature
, vol.434
, pp. 913-917
-
-
Bryant, H.E.1
Schultz, N.2
Thomas, H.D.3
Parker, K.M.4
Flower, D.5
Lopez, E.6
Kyle, S.7
Meuth, M.8
Curtin, N.J.9
Helleday, T.10
-
5
-
-
0029125820
-
K-ras mutation and pancreatic adenocarcinoma
-
Caldas C., Kern S.E. K-ras mutation and pancreatic adenocarcinoma. Int. J. Pancreatol. 1995, 18:1-6.
-
(1995)
Int. J. Pancreatol.
, vol.18
, pp. 1-6
-
-
Caldas, C.1
Kern, S.E.2
-
6
-
-
0032574733
-
The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment
-
Chen P.L., Chen C.F., Chen Y., Xiao J., Sharp Z.D., Lee W.H. The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. Proc. Natl. Acad. Sci. USA 1998, 95:5287-5292.
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 5287-5292
-
-
Chen, P.L.1
Chen, C.F.2
Chen, Y.3
Xiao, J.4
Sharp, Z.D.5
Lee, W.H.6
-
7
-
-
0029007696
-
Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13
-
Collins N., McManus R., Wooster R., Mangion J., Seal S., Lakhani S.R., Ormiston W., Daly P.A., Ford D., Easton D.F., et al. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 1995, 10:1673-1675.
-
(1995)
Oncogene
, vol.10
, pp. 1673-1675
-
-
Collins, N.1
McManus, R.2
Wooster, R.3
Mangion, J.4
Seal, S.5
Lakhani, S.R.6
Ormiston, W.7
Daly, P.A.8
Ford, D.9
Easton, D.F.10
-
8
-
-
33847762750
-
The prevalence of BRCA2 mutations in familial pancreatic cancer
-
Couch F.J., Johnson M.R., Rabe K.G., Brune K., de Andrade M., Goggins M., Rothenmund H., Gallinger S., Klein A., Petersen G.M., et al. The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 2007, 16:342-346.
-
(2007)
Cancer Epidemiol. Biomarkers Prev.
, vol.16
, pp. 342-346
-
-
Couch, F.J.1
Johnson, M.R.2
Rabe, K.G.3
Brune, K.4
de Andrade, M.5
Goggins, M.6
Rothenmund, H.7
Gallinger, S.8
Klein, A.9
Petersen, G.M.10
-
9
-
-
33749007676
-
Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects
-
Evers B., Jonkers J. Mouse models of BRCA1 and BRCA2 deficiency: past lessons, current understanding and future prospects. Oncogene 2006, 25:5885-5897.
-
(2006)
Oncogene
, vol.25
, pp. 5885-5897
-
-
Evers, B.1
Jonkers, J.2
-
10
-
-
17244373777
-
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
-
Farmer H., McCabe N., Lord C.J., Tutt A.N., Johnson D.A., Richardson T.B., Santarosa M., Dillon K.J., Hickson I., Knights C., et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 2005, 434:917-921.
-
(2005)
Nature
, vol.434
, pp. 917-921
-
-
Farmer, H.1
McCabe, N.2
Lord, C.J.3
Tutt, A.N.4
Johnson, D.A.5
Richardson, T.B.6
Santarosa, M.7
Dillon, K.J.8
Hickson, I.9
Knights, C.10
-
11
-
-
67650471685
-
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers
-
Fong P.C., Boss D.S., Yap T.A., Tutt A., Wu P., Mergui-Roelvink M., Mortimer P., Swaisland H., Lau A., O'Connor M.J., et al. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N. Engl. J. Med. 2009, 361:123-134.
-
(2009)
N. Engl. J. Med.
, vol.361
, pp. 123-134
-
-
Fong, P.C.1
Boss, D.S.2
Yap, T.A.3
Tutt, A.4
Wu, P.5
Mergui-Roelvink, M.6
Mortimer, P.7
Swaisland, H.8
Lau, A.9
O'Connor, M.J.10
-
12
-
-
77954032829
-
Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval
-
Fong P.C., Yap T.A., Boss D.S., Carden C.P., Mergui-Roelvink M., Gourley C., De Greve J., Lubinski J., Shanley S., Messiou C., et al. Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval. J. Clin. Oncol. 2010, 28:2512-2519.
-
(2010)
J. Clin. Oncol.
, vol.28
, pp. 2512-2519
-
-
Fong, P.C.1
Yap, T.A.2
Boss, D.S.3
Carden, C.P.4
Mergui-Roelvink, M.5
Gourley, C.6
De Greve, J.7
Lubinski, J.8
Shanley, S.9
Messiou, C.10
-
13
-
-
0032054158
-
Thymic lymphomas in mice with a truncating mutation in Brca2
-
Friedman L.S., Thistlethwaite F.C., Patel K.J., Yu V.P., Lee H., Venkitaraman A.R., Abel K.J., Carlton M.B., Hunter S.M., Colledge W.H., et al. Thymic lymphomas in mice with a truncating mutation in Brca2. Cancer Res. 1998, 58:1338-1343.
-
(1998)
Cancer Res.
, vol.58
, pp. 1338-1343
-
-
Friedman, L.S.1
Thistlethwaite, F.C.2
Patel, K.J.3
Yu, V.P.4
Lee, H.5
Venkitaraman, A.R.6
Abel, K.J.7
Carlton, M.B.8
Hunter, S.M.9
Colledge, W.H.10
-
14
-
-
34548247158
-
Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer
-
Gallmeier E., Hucl T., Calhoun E.S., Cunningham S.C., Bunz F., Brody J.R., Kern S.E. Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer. Cancer Biol. Ther. 2007, 6:654-660.
-
(2007)
Cancer Biol. Ther.
, vol.6
, pp. 654-660
-
-
Gallmeier, E.1
Hucl, T.2
Calhoun, E.S.3
Cunningham, S.C.4
Bunz, F.5
Brody, J.R.6
Kern, S.E.7
-
15
-
-
0034090681
-
High-thoroughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR
-
Germer S., Holland M.J., Higuchi R. High-thoroughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res. 2000, 10:258-266.
-
(2000)
Genome Res.
, vol.10
, pp. 258-266
-
-
Germer, S.1
Holland, M.J.2
Higuchi, R.3
-
16
-
-
12644253827
-
Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas
-
Goggins M., Schutte M., Lu J., Moskaluk C.A., Weinstein C.L., Petersen G.M., Yeo C.J., Jackson C.E., Lynch H.T., Hruban R.H., et al. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. 1996, 56:5360-5364.
-
(1996)
Cancer Res.
, vol.56
, pp. 5360-5364
-
-
Goggins, M.1
Schutte, M.2
Lu, J.3
Moskaluk, C.A.4
Weinstein, C.L.5
Petersen, G.M.6
Yeo, C.J.7
Jackson, C.E.8
Lynch, H.T.9
Hruban, R.H.10
-
17
-
-
0033842724
-
BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications
-
Goggins M., Hruban R.H., Kern S.E. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. Am. J. Pathol. 2000, 156:1767-1771.
-
(2000)
Am. J. Pathol.
, vol.156
, pp. 1767-1771
-
-
Goggins, M.1
Hruban, R.H.2
Kern, S.E.3
-
18
-
-
0028819984
-
Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13
-
Gudmundsson J., Johannesdottir G., Bergthorsson J.T., Arason A., Ingvarsson S., Egilsson V., Barkardottir R.B. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. Cancer Res. 1995, 55:4830-4832.
-
(1995)
Cancer Res.
, vol.55
, pp. 4830-4832
-
-
Gudmundsson, J.1
Johannesdottir, G.2
Bergthorsson, J.T.3
Arason, A.4
Ingvarsson, S.5
Egilsson, V.6
Barkardottir, R.B.7
-
19
-
-
0037420026
-
BRCA2 germline mutations in familial pancreatic carcinoma
-
Hahn S.A., Greenhalf B., Ellis I., Sina-Frey M., Rieder H., Korte B., Gerdes B., Kress R., Ziegler A., Raeburn J.A., et al. BRCA2 germline mutations in familial pancreatic carcinoma. J. Natl. Cancer Inst. 2003, 95:214-221.
-
(2003)
J. Natl. Cancer Inst.
, vol.95
, pp. 214-221
-
-
Hahn, S.A.1
Greenhalf, B.2
Ellis, I.3
Sina-Frey, M.4
Rieder, H.5
Korte, B.6
Gerdes, B.7
Kress, R.8
Ziegler, A.9
Raeburn, J.A.10
-
20
-
-
33646577163
-
Genetics and biology of pancreatic ductal adenocarcinoma
-
Hezel A.F., Kimmelman A.C., Stanger B.Z., Bardeesy N., Depinho R.A. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2006, 20:1218-1249.
-
(2006)
Genes Dev.
, vol.20
, pp. 1218-1249
-
-
Hezel, A.F.1
Kimmelman, A.C.2
Stanger, B.Z.3
Bardeesy, N.4
Depinho, R.A.5
-
21
-
-
9144266295
-
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
-
Hingorani S.R., Petricoin E.F., Maitra A., Rajapakse V., King C., Jacobetz M.A., Ross S., Conrads T.P., Veenstra T.D., Hitt B.A., et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003, 4:437-450.
-
(2003)
Cancer Cell
, vol.4
, pp. 437-450
-
-
Hingorani, S.R.1
Petricoin, E.F.2
Maitra, A.3
Rajapakse, V.4
King, C.5
Jacobetz, M.A.6
Ross, S.7
Conrads, T.P.8
Veenstra, T.D.9
Hitt, B.A.10
-
22
-
-
19344362405
-
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
-
Hingorani S.R., Wang L., Multani A.S., Combs C., Deramaudt T.B., Hruban R.H., Rustgi A.K., Chang S., Tuveson D.A. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 2005, 7:469-483.
-
(2005)
Cancer Cell
, vol.7
, pp. 469-483
-
-
Hingorani, S.R.1
Wang, L.2
Multani, A.S.3
Combs, C.4
Deramaudt, T.B.5
Hruban, R.H.6
Rustgi, A.K.7
Chang, S.8
Tuveson, D.A.9
-
23
-
-
0035020633
-
Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions
-
Hruban R.H., Adsay N.V., Albores-Saavedra J., Compton C., Garrett E.S., Goodman S.N., Kern S.E., Klimstra D.S., Kloppel G., Longnecker D.S., et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am. J. Surg. Pathol. 2001, 25:579-586.
-
(2001)
Am. J. Surg. Pathol.
, vol.25
, pp. 579-586
-
-
Hruban, R.H.1
Adsay, N.V.2
Albores-Saavedra, J.3
Compton, C.4
Garrett, E.S.5
Goodman, S.N.6
Kern, S.E.7
Klimstra, D.S.8
Kloppel, G.9
Longnecker, D.S.10
-
24
-
-
33751207530
-
-
American Registry of Pathology, Annapolis Junction, MD, AFIP ATLAS of Tumour Pathology, Series
-
Hruban R., Pitman M., Klimstra D.S. Tumors of the Pancreas 2007, AFIP ATLAS of Tumour Pathology, Series IV. American Registry of Pathology, Annapolis Junction, MD.
-
(2007)
Tumors of the Pancreas
, vol.4
-
-
Hruban, R.1
Pitman, M.2
Klimstra, D.S.3
-
25
-
-
64849092309
-
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene
-
Jones S., Hruban R.H., Kamiyama M., Borges M., Zhang X., Parsons D.W., Lin J.C., Palmisano E., Brune K., Jaffee E.M., et al. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 2009, 324:217.
-
(2009)
Science
, vol.324
, pp. 217
-
-
Jones, S.1
Hruban, R.H.2
Kamiyama, M.3
Borges, M.4
Zhang, X.5
Parsons, D.W.6
Lin, J.C.7
Palmisano, E.8
Brune, K.9
Jaffee, E.M.10
-
26
-
-
0035734285
-
Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer
-
Jonkers J., Meuwissen R., van der Gulden H., Peterse H., van der Valk M., Berns A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat. Genet. 2001, 29:418-425.
-
(2001)
Nat. Genet.
, vol.29
, pp. 418-425
-
-
Jonkers, J.1
Meuwissen, R.2
van der Gulden, H.3
Peterse, H.4
van der Valk, M.5
Berns, A.6
-
27
-
-
34548564536
-
Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis
-
King T.A., Li W., Brogi E., Yee C.J., Gemignani M.L., Olvera N., Levine D.A., Norton L., Robson M.E., Offit K., et al. Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis. Ann. Surg. Oncol. 2007, 14:2510-2518.
-
(2007)
Ann. Surg. Oncol.
, vol.14
, pp. 2510-2518
-
-
King, T.A.1
Li, W.2
Brogi, E.3
Yee, C.J.4
Gemignani, M.L.5
Olvera, N.6
Levine, D.A.7
Norton, L.8
Robson, M.E.9
Offit, K.10
-
28
-
-
0015043748
-
Mutation and cancer: statistical study of retinoblastoma
-
Knudson A.G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 1971, 68:820-823.
-
(1971)
Proc. Natl. Acad. Sci. USA
, vol.68
, pp. 820-823
-
-
Knudson, A.G.1
-
29
-
-
0030924656
-
Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos
-
Ludwig T., Chapman D.L., Papaioannou V.E., Efstratiadis A. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev. 1997, 11:1226-1241.
-
(1997)
Genes Dev.
, vol.11
, pp. 1226-1241
-
-
Ludwig, T.1
Chapman, D.L.2
Papaioannou, V.E.3
Efstratiadis, A.4
-
32
-
-
10944236962
-
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
-
Olive K.P., Tuveson D.A., Ruhe Z.C., Yin B., Willis N.A., Bronson R.T., Crowley D., Jacks T. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 2004, 119:847-860.
-
(2004)
Cell
, vol.119
, pp. 847-860
-
-
Olive, K.P.1
Tuveson, D.A.2
Ruhe, Z.C.3
Yin, B.4
Willis, N.A.5
Bronson, R.T.6
Crowley, D.7
Jacks, T.8
-
33
-
-
67149143399
-
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer
-
Olive K.P., Jacobetz M.A., Davidson C.J., Gopinathan A., McIntyre D., Honess D., Madhu B., Goldgraben M.A., Caldwell M.E., Allard D., et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009, 324:1457-1461.
-
(2009)
Science
, vol.324
, pp. 1457-1461
-
-
Olive, K.P.1
Jacobetz, M.A.2
Davidson, C.J.3
Gopinathan, A.4
McIntyre, D.5
Honess, D.6
Madhu, B.7
Goldgraben, M.A.8
Caldwell, M.E.9
Allard, D.10
-
34
-
-
0037052688
-
Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer
-
Osorio A., de la Hoya M., Rodriguez-Lopez R., Martinez-Ramirez A., Cazorla A., Granizo J.J., Esteller M., Rivas C., Caldes T., Benitez J. Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer. Int. J. Cancer 2002, 99:305-309.
-
(2002)
Int. J. Cancer
, vol.99
, pp. 305-309
-
-
Osorio, A.1
de la Hoya, M.2
Rodriguez-Lopez, R.3
Martinez-Ramirez, A.4
Cazorla, A.5
Granizo, J.J.6
Esteller, M.7
Rivas, C.8
Caldes, T.9
Benitez, J.10
-
36
-
-
0028308492
-
P53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions
-
Redston M.S., Caldas C., Seymour A.B., Hruban R.H., da Costa L., Yeo C.J., Kern S.E. p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions. Cancer Res. 1994, 54:3025-3033.
-
(1994)
Cancer Res.
, vol.54
, pp. 3025-3033
-
-
Redston, M.S.1
Caldas, C.2
Seymour, A.B.3
Hruban, R.H.4
da Costa, L.5
Yeo, C.J.6
Kern, S.E.7
-
37
-
-
0035813127
-
Analysis of murine Brca2 reveals conservation of protein-protein interactions but differences in nuclear localization signals
-
Sarkisian C.J., Master S.R., Huber L.J., Ha S.I., Chodosh L.A. Analysis of murine Brca2 reveals conservation of protein-protein interactions but differences in nuclear localization signals. J. Biol. Chem. 2001, 276:37640-37648.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 37640-37648
-
-
Sarkisian, C.J.1
Master, S.R.2
Huber, L.J.3
Ha, S.I.4
Chodosh, L.A.5
-
38
-
-
3242697219
-
Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RAS(G12V) oncogene
-
Schreiber F.S., Deramaudt T.B., Brunner T.B., Boretti M.I., Gooch K.J., Stoffers D.A., Bernhard E.J., Rustgi A.K. Successful growth and characterization of mouse pancreatic ductal cells: functional properties of the Ki-RAS(G12V) oncogene. Gastroenterology 2004, 127:250-260.
-
(2004)
Gastroenterology
, vol.127
, pp. 250-260
-
-
Schreiber, F.S.1
Deramaudt, T.B.2
Brunner, T.B.3
Boretti, M.I.4
Gooch, K.J.5
Stoffers, D.A.6
Bernhard, E.J.7
Rustgi, A.K.8
-
39
-
-
0030140026
-
A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes
-
Thorlacius S., Olafsdottir G., Tryggvadottir L., Neuhausen S., Jonasson J.G., Tavtigian S.V., Tulinius H., Ogmundsdottir H.M., Eyfjord J.E. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat. Genet. 1996, 13:117-119.
-
(1996)
Nat. Genet.
, vol.13
, pp. 117-119
-
-
Thorlacius, S.1
Olafsdottir, G.2
Tryggvadottir, L.3
Neuhausen, S.4
Jonasson, J.G.5
Tavtigian, S.V.6
Tulinius, H.7
Ogmundsdottir, H.M.8
Eyfjord, J.E.9
-
40
-
-
0030956589
-
Study of a single BRCA2 mutation with high carrier frequency in a small population
-
Thorlacius S., Sigurdsson S., Bjarnadottir H., Olafsdottir G., Jonasson J.G., Tryggvadottir L., Tulinius H., Eyfjord J.E. Study of a single BRCA2 mutation with high carrier frequency in a small population. Am. J. Hum. Genet. 1997, 60:1079-1084.
-
(1997)
Am. J. Hum. Genet.
, vol.60
, pp. 1079-1084
-
-
Thorlacius, S.1
Sigurdsson, S.2
Bjarnadottir, H.3
Olafsdottir, G.4
Jonasson, J.G.5
Tryggvadottir, L.6
Tulinius, H.7
Eyfjord, J.E.8
-
41
-
-
77955019276
-
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
-
Tutt A., Robson M., Garber J.E., Domchek S.M., Audeh M.W., Weitzel J.N., Friedlander M., Arun B., Loman N., Schmutzler R.K., et al. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial. Lancet 2010, 376:235-244.
-
(2010)
Lancet
, vol.376
, pp. 235-244
-
-
Tutt, A.1
Robson, M.2
Garber, J.E.3
Domchek, S.M.4
Audeh, M.W.5
Weitzel, J.N.6
Friedlander, M.7
Arun, B.8
Loman, N.9
Schmutzler, R.K.10
-
42
-
-
27144532118
-
In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor
-
van der Heijden M.S., Brody J.R., Dezentje D.A., Gallmeier E., Cunningham S.C., Swartz M.J., DeMarzo A.M., Offerhaus G.J., Isacoff W.H., Hruban R.H., et al. In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor. Clin. Cancer Res. 2005, 11:7508-7515.
-
(2005)
Clin. Cancer Res.
, vol.11
, pp. 7508-7515
-
-
van der Heijden, M.S.1
Brody, J.R.2
Dezentje, D.A.3
Gallmeier, E.4
Cunningham, S.C.5
Swartz, M.J.6
DeMarzo, A.M.7
Offerhaus, G.J.8
Isacoff, W.H.9
Hruban, R.H.10
-
43
-
-
63049108452
-
Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment
-
Venkitaraman A.R. Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. Annu. Rev. Pathol. 2009, 4:461-487.
-
(2009)
Annu. Rev. Pathol.
, vol.4
, pp. 461-487
-
-
Venkitaraman, A.R.1
-
44
-
-
0031466027
-
RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2
-
Wong A.K., Pero R., Ormonde P.A., Tavtigian S.V., Bartel P.L. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J. Biol. Chem. 1997, 272:31941-31944.
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 31941-31944
-
-
Wong, A.K.1
Pero, R.2
Ormonde, P.A.3
Tavtigian, S.V.4
Bartel, P.L.5
-
45
-
-
0033179235
-
BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo
-
Yuan S.S., Lee S.Y., Chen G., Song M., Tomlinson G.E., Lee E.Y. BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. Cancer Res. 1999, 59:3547-3551.
-
(1999)
Cancer Res.
, vol.59
, pp. 3547-3551
-
-
Yuan, S.S.1
Lee, S.Y.2
Chen, G.3
Song, M.4
Tomlinson, G.E.5
Lee, E.Y.6
|